Text Size

Efficacy of Modified Ketogenic Diet (Atkins) in Management of Epilepsy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2004 by University Health Network, Toronto.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
University Health Network, Toronto
ClinicalTrials.gov Identifier:
NCT00188500
First received: September 12, 2005
Last updated: December 28, 2005
Last verified: March 2004
History of Changes
  Purpose

The purpose of this study is to determine whether patients with uncontrolled epilepsy can follow a low carbohydrate diet long-term and if so, how will that diet affect their seizures


Condition Intervention
Epilepsy
 Behavioral: atkins diet
Behavioral: ability to follow low carbohydrate diet

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Efficacy, Tolerability and Long-Term Adherence of a Modified Ketogenic Diet (Atkins) in the Management of Pharmacoresistant Epilepsy

Resource links provided by NLM:

MedlinePlus related topics: Epilepsy Seizures
U.S. FDA Resources

Further study details as provided by University Health Network, Toronto:

Primary Outcome Measures:
  • seizure reduction

Secondary Outcome Measures:
  • cognitive improvement

Study Start Date: August 2005
Estimated Study Completion Date: September 2005
Detailed Description:

In the management of drug-resistant epilepsy, many strategies have been examined. The Ketogenic Diet, high in fats and low in all other nutrients was observed to be of benefit. However, due to its complexedness and unpalatability, this diet is rarely used in the adult population. A recent small study showed seizure reduction with the Atkins Diet.

In this study, patients will be randomized into one of 2 groups- group 1 receiving limited dietary instruction for the Atkins Diet and group 2- receiving detailed dietary instruction. A seizure severity-matched control group will also take part. We will follow these patients over a period of 2 years looking at seizure frequency, weight, sustainability of the diet, effect on anti-epilepsy medication dosage, effect in cognition, quality of life and financial impact of the diet.

Patients will come to clinic to see the dietitian at specific intervals. cognitive testing will also be done at the beginning of the study and every 6 months thereafter. Patients will keep food charts, ketosis charts and seizure diaries.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:medically refractory partial epilepsy financial ability to pay for higher priced food

-

Exclusion Criteria:

  • Low BMI
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00188500

Contacts
Contact: Nina Politzer 416 603-5800 ext 2446

Locations
Canada, Ontario
Toronto Western Hospital Recruiting
Toronto, Ontario, Canada, M5T 2S8
Contact: Nina Politzer, BScN     416 603-5800 ext 2446     politzer@uhnres.utoronto.ca    
Principal Investigator: J. Martin delCampo, MD FRCP(C)            
Sponsors and Collaborators
University Health Network, Toronto
Investigators
Principal Investigator: J Martin delCampo UHN
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00188500     History of Changes
Other Study ID Numbers: 05-0027-AE
Study First Received: September 12, 2005
Last Updated: December 28, 2005
Health Authority: Canada: Health Canada

Keywords provided by University Health Network, Toronto:
epilepsy
atkins diet

Additional relevant MeSH terms:
Epilepsy
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases

ClinicalTrials.gov processed this record on May 19, 2013